Cargando…
Sintilimab-induced inflammatory myopathy in a patient with esophageal cancer: a case report
The use of immune checkpoint inhibitors (ICIs) has shown remarkable efficacy in the treatment of various malignancies, significantly reshaping cancer treatment. However, as a result of the widespread use of ICIs, several immune-related adverse events (iRAEs) have emerged, some of which can be rare a...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619899/ https://www.ncbi.nlm.nih.gov/pubmed/37920461 http://dx.doi.org/10.3389/fimmu.2023.1253463 |